BioMark Announces Partnership With The Metabolomics Innovation Centre - Biomark Diagnostics

News

March 27, 2015

BioMark Announces Partnership With The Metabolomics Innovation Centre

BioMark Diagnostics Inc.

BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.

BIOMARK_ANNOUNCES_PARTNERSHIP_WITH_THE_METABOLOMICS_INNOVATION_CENTRE (PDF)

———————————————

Share this post:

Categories

Archives

Sign up for the latest Biomark news

No paperwork, no hassle. We keep things digital, easy and regular.

*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.

BioMark Diagnostics Inc.

CSE: BUX
OTC: BMKDF
FSE: 20B

More Information

Investors

Related articles ...

biomark diagnostics qtrap 6500 mass spectrometer

Articles and Information

BioMark’s Quebec Laboratory Begins To Take Shape

BioMark Diagnostics is pleased to announce that the installation of its Quebec laboratory is now

September 22, 2021

News

Biomark to Expand Treatment Response Trial to Advanced Lung Cancer Patient Receiving Immunotherapy

Vancouver, British Columbia – (June 29th, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE:

June 29, 2021

News

BIOMARK RECEIVES $825K GRANT TO DEVELOP ITS LIQUID BIOPSY ASSAY FOR LUNG CANCER SCREENING

Vancouver, British Columbia – (June 1st, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE:

June 1, 2021

News

BIOMARK REÇOIT UNE SUBVENTION DE 825 K $ POUR DÉVELOPPER SON TEST DE BIOPSIE LIQUIDE POUR LE DÉPISTAGE DU CANCER DU POUMON

Vancouver, Colombie-Britannique – (1er juin 2021) – BioMark Diagnostics Inc. («BioMark») (CSE: BUX) (FSE: 20B)

June 1, 2021

News

BIOMARK ANNOUNCES CHANGE OF AUDITOR

Vancouver, British Columbia – (May 31, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE:

May 31, 2021

© 2021 BioMark Diagnostics Inc. All Rights Reserved. BioMark’s mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.